Phase II study of dasatinib in the treatment of head and neck squamous cell carcinoma (HNSCC)

PURPOSE: Treatment options for patients with advanced HNSCC are scarce. This phase II study was conducted to evaluate the safety, tolerability, PK, and efficacy of dasatinib in this setting. EXPERIMENTAL DESIGN: Patients with recurrent and/or metastatic HNSCC after platinum-based therapy were treate...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Brooks, Heather D., Glisson, Bonnie S., Bekele, B. Nebiyou, Ginsberg, Lawrence E., El-Naggar, Adel, Culotta, Kirk S., Takebe, Naoko, Wright, John, Tran, Hai T., Papadimitrakopoulou, Vassiliki A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117018/
https://ncbi.nlm.nih.gov/pubmed/21523723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25769
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky